Carboplatin is a type of chemotherapy medicine used to treat cancer. It works by stopping cancer cells from growing and dividing. It's often given in combination with other drugs to make it more effective. Your doctor will decide if this medicine is right for you based on your specific type of cancer.
Every report comes from a Lived member, sent anonymously.
Have you tried Carboplatin for Ovarian Tumors?
Carboplatin is a chemotherapy medicine from the platinum-based family of cancer drugs. It was first sold under the brand name Paraplatin, which has since been discontinued in the US; today it is usually given as generic carboplatin, and a newer brand called Kyxata, a ready-to-use form of the same medicine, is also available. In the US, carboplatin is approved for adults with ovarian cancer: combined with other chemotherapy as the first treatment for advanced disease, and on its own when the cancer comes back after earlier chemotherapy. Cancer specialists also use it widely outside that formal approval, including for lung, breast, bladder, endometrial, cervical, testicular and head and neck cancers, and for some childhood cancers such as retinoblastoma (an eye cancer) and neuroblastoma. It is often chosen in place of cisplatin, an older platinum drug, because it causes less vomiting and is easier on the kidneys while working in a similar way.
Cancer cells divide far more often than most healthy cells, and each division requires copying their DNA. Once inside the body, carboplatin binds to DNA and forms cross-links that tie the strands together. A cell with cross-linked DNA cannot copy it properly, so it stops dividing and dies. This damage is not limited to cancer. Healthy cells that also divide quickly, especially the blood-forming cells in the bone marrow, are affected too, which is why lower blood counts are the main limit on how much carboplatin a person can receive.
Carboplatin is not a pill. It is given as an intravenous (IV) infusion into a vein, by a nurse in a hospital or outpatient infusion center, and the infusion itself takes at least 15 minutes. Each dose begins a treatment cycle, and the next dose is usually given three or four weeks later, once blood counts have recovered. Medicines to prevent nausea are given before each infusion. The dose is calculated for each person. Because the kidneys clear carboplatin from the body, the care team usually works out the dose from a measure of kidney function and a target level of drug exposure, rather than from body size alone. This helps avoid overdosing people whose kidneys clear the drug more slowly. The number of cycles depends on the cancer and the regimen; six cycles is common for first treatment of ovarian cancer.
Nausea and vomiting are common but usually ease within a day of the infusion and respond well to anti-nausea medicines. Tiredness, constipation or diarrhea, and changes in taste can follow. Hair loss is uncommon when carboplatin is used alone but more likely when it is combined with other chemotherapy drugs. Tingling or numbness in the hands and feet (peripheral neuropathy) can develop, especially in people over 65 or those previously treated with cisplatin. Ringing in the ears, hearing loss or sudden changes in vision should also be reported promptly. Blood tests often show low magnesium and other minerals, which the team may replace. The most important effect is on blood counts. White cells, platelets and red cells usually reach their lowest point about three weeks after a dose. Low white cells raise the risk of serious infection, low platelets raise the risk of bleeding, and low red cells (anemia) cause tiredness and can build up over several cycles, sometimes needing a transfusion. Call the care team right away for a fever, chills, sore throat or other signs of infection, or for unusual bruising or bleeding, black or bloody stools, or vomit that is bloody or looks like coffee grounds. Allergic reactions can happen within minutes of an infusion starting, and they become more likely after several cycles or for people who have had platinum drugs before. Tell the nurse at once about itching, flushing, a rash, chest tightness, trouble breathing or feeling faint; infusion teams are equipped to stop the drip and treat a reaction immediately.
Carboplatin is not used in people who have had a severe allergic reaction to cisplatin or another platinum drug, whose bone marrow is already badly depleted, or who have significant bleeding. Effects on blood counts add up when carboplatin is combined with other chemotherapy or radiation therapy, which the team accounts for when planning doses. Aminoglycosides, a group of strong antibiotics such as gentamicin and tobramycin usually given in the hospital, can increase kidney damage and hearing loss when given alongside carboplatin, so they are generally avoided. Carboplatin can harm a developing baby. Women who could become pregnant are advised to use effective contraception during treatment and for 6 months after the last dose, and men with partners who could become pregnant for 3 months after. Breastfeeding is not recommended during treatment or for one week afterward. Like other chemotherapy that damages DNA, carboplatin may increase the risk of developing another cancer later in life.
Treatment follows a rhythm. Each infusion day usually starts with blood tests and a check-in, followed by anti-nausea medicine and the infusion. Nausea, if it comes, is usually worst in the first day or two. Blood counts tend to fall to their lowest roughly three weeks after an infusion, which is when infection and bleeding are most likely, and they usually recover by the next scheduled dose. The team checks counts regularly to decide whether the next cycle can go ahead on schedule or should be delayed or reduced. How well carboplatin works depends on the type and stage of cancer and on the other treatments it is paired with. Progress is usually checked with scans and blood tests after a few cycles. Some effects, such as tingling in the hands and feet or hearing changes, can outlast treatment, so mention them early rather than waiting for them to worsen.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Carboplatin, what you've noticed, or ask the community a question.